Addressing maternal mortality: the pregnant cardiac patient

Published:September 29, 2018DOI:
      Cardiac disease in pregnancy is the number one indirect cause of maternal mortality in the United States. We propose a triad solution that includes universal screening for cardiovascular disease in pregnancy and postpartum women, patient education, and institution of a multidisciplinary cardiac team. Additionally, we emphasize essential elements to maximize care for the pregnant cardiac patient based on our experience at our institution in Bronx, NY.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Creanga A.A.
        • Berg C.J.
        • Syverson C.
        • Seed K.
        • Bruce F.C.
        • Callaghan W.M.
        Pregnancy-related mortality in the United States, 2006–2010.
        Obstet Gynecol. 2015; 125: 5-12
        • MacDorman M.F.
        • Declercq E.
        • Cabral H.
        • Morton C.
        Recent increases in the U.S. maternal mortality rate: disentangling trends from measurement issues.
        Obstet Gynecol. 2016; 128: 447-455
        • Creanga A.A.
        • Callaghan W.M.
        Recent increases in the US maternal mortality rate: disentangling trends from measurement issues.
        Obstet Gynecol. 2017; 129: 206-207
        • Clark S.L.
        • Belfort M.A.
        The case for a national maternal mortality review committee.
        Obstet Gynecol. 2017; 130: 198-202
        • Hameed A.B.
        • Lawton E.S.
        • McCain C.L.
        • et al.
        Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy.
        Am J Obstet Gynecol. 2015; 213: 379.e1-379.e10
        • Ladouceur M.
        • Calderon J.
        • Traore M.
        • et al.
        Educational needs of adolescents with congenital heart disease: impact of a transition intervention programme.
        Arch Cardiovasc Dis. 2017; 110: 317-324
        • Roos-Hesselink J.W.
        • Cornette J.
        • Sliwa K.
        • Pieper P.G.
        • Veldtman G.R.
        • Johnson M.R.
        Contraception and cardiovascular disease.
        Eur Heart J. 2015; 36 (1734a-b): 1728-1734
        • Mittal P.
        • Dandekar A.
        • Hessler D.
        Use of a modified reproductive life plan to improve awareness of preconception health in women with chronic disease.
        Perm J. 2014; 18: 28-32
        • Regitz-Zagrosek V.
        • Roos-Hesselink J.W.
        • Bauersachs J.
        • et al.
        2018 ESC guidelines for the management of cardiovascular diseases during pregnancy.
        Eur Heart J. 2018; 39: 3165-3241
        • European Society of Gynecology, Association for European Paediatric Cardiology, German Society for Gender Medicine, et al
        ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).
        Eur Heart J. 2011; 32: 3147-3197
        • Elkayam U.
        • Goland S.
        • Pieper P.G.
        • Silverside C.K.
        High-risk cardiac disease in pregnancy: part I.
        J Am Coll Cardiol. 2016; 68: 396-410
        • Ando T.
        • Kaur R.
        • Holmes A.A.
        • Brusati A.
        • Fujikura K.
        • Taub C.C.
        Physiological adaptation of the left ventricle during the second and third trimesters of a healthy pregnancy: a speckle tracking echocardiography study.
        Am J Cardiovasc Dis. 2015; 5: 119-126
        • Hameed A.B.
        • Chan K.
        • Ghamsary M.
        • Elkayam U.
        Longitudinal changes in the B-type natriuretic peptide levels in normal pregnancy and postpartum.
        Clin Cardiol. 2009; 32: E60-E62
        • Yurteri-Kaplan L.
        • Saber S.
        • Zamudio S.
        • et al.
        Brain natriuretic peptide in term pregnancy.
        Reprod Sci. 2012; 19: 520-525
        • Burlingame J.M.
        • Yamasato K.
        • Ahn H.J.
        • Seto T.
        • Tang W.H.W.
        B-type natriuretic peptide and echocardiography reflect volume changes during pregnancy.
        J Perinat Med. 2017; 45: 577-583
        • Mayama M.
        • Yoshihara M.
        • Uno K.
        • et al.
        Factors influencing brain natriuretic peptide levels in healthy pregnant women.
        Int J Cardiol. 2017; 228: 749-753
        • Siu S.C.
        • Sermer M.
        • Colman J.M.
        • et al.
        Prospective multicenter study of pregnancy outcomes in women with heart disease.
        Circulation. 2001; 104: 515-521
        • Silversides C.K.
        • Grewal J.
        • Mason J.
        • et al.
        Pregnancy outcomes in women with heart disease: the CARPREG II Study.
        J Am Coll Cardiol. 2018; 71: 2419-2430
        • Drenthen W.
        • Boersma E.
        • Balci A.
        • et al.
        Predictors of pregnancy complications in women with congenital heart disease.
        Eur Heart J. 2010; 31: 2124-2132
        • Regitz-Zagrosek V.
        • Lundqvist C.B.
        • Borghi C.
        • et al.
        [ESC guidelines for treatment of cardiovascular disease in pregnancy].
        Turk Kardiyol Dern Ars. 2012; 40: 70-120
        • van Hagen I.M.
        • Boersma E.
        • Johnson M.R.
        • et al.
        Global cardiac risk assessment in the Registry of Pregnancy and Cardiac disease: results of a registry from the European Society of Cardiology.
        Eur J Heart Fail. 2016; 18: 523-533
        • Sliwa K.
        • van Hagen I.M.
        • Budts W.
        • et al.
        Pulmonary hypertension and pregnancy outcomes: data from the Registry of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology.
        Eur J Heart Fail. 2016; 18: 1119-1128
        • Goland S.
        • van Hagen I.M.
        • Elbaz-Greener G.
        • et al.
        Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC).
        Eur Heart J. 2017; 38: 2683-2690
        • Silversides C.K.
        • Spears D.A.
        Atrial fibrillation and atrial flutter in pregnant women with heart disease: contributions from the ROPAC Investigators.
        JACC Clin Electrophysiol. 2015; 1: 293-295
        • Tepper N.K.
        • Curtis K.M.
        • Jatlaoui T.C.
        • Whiteman M.K.
        Updated guidance for safe and effective use of contraception.
        J Womens Health (Larchmt). 2016; 25: 1097-1101